Bank of America reports 4.1% stake in Novavax

Rhea-AI Filing Summary

Bank of America Corporation filed an amendment to a Schedule 13G disclosing beneficial ownership of 6,655,398 shares of Novavax Inc. The filing states this stake represents 4.1% of the class, calculated using 162,935,945 outstanding shares as of February 16, 2026. The statement attributes shared voting power of 6,653,929 and shared dispositive power of 6,655,398 across Bank of America and specified subsidiaries.

Insights

Equity Ownership Analyst

Routine Schedule 13G/A shows a non-controlling institutional stake.

The amendment records 4.1% beneficial ownership by Bank of America Corporation and certain subsidiaries, using February 16, 2026 share totals. This is a passive disclosure under beneficial-ownership rules rather than an active acquisition statement.

Cash-flow treatment and plan for the holdings are not stated; subsequent filings would be required to show any change in stake or voting strategy.

Key Figures

Shares beneficially owned: 6,655,398 shares Percent of class: 4.1% Shares outstanding used: 162,935,945 shares +1 more

4 metrics

Shares beneficially owned 6,655,398 shares Amount reported by Bank of America on Schedule 13G/A

Percent of class 4.1% Calculated using shares outstanding as of <date>February 16, 2026</date>

Shares outstanding used 162,935,945 shares Issuer's Form 10-K share total reported as of <date>February 16, 2026</date>

Shared voting power 6,653,929 shares Shared power to vote reported in Item 4

Key Terms

Schedule 13G/A, Beneficial ownership, Shared dispositive power, Parent holding company

4 terms

Schedule 13G/A regulatory

"Amendment to Schedule 13G reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 6,655,398.00 (b) Percent of class: 4.1%"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Shared dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 6,655,398.00"

Parent holding company regulatory

"statement on is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in Novavax (NVAX) does Bank of America report?

Bank of America reports ownership of 6,655,398 shares, or 4.1% of NVAX. The filing cites 162,935,945 shares outstanding as of February 16, 2026, which was used to calculate the 4.1% ownership percentage.

Which Bank of America entities are included in the Schedule 13G/A filing?

The filing covers Bank of America Corporation and specified subsidiaries. It lists BofA Securities, Inc.; Bank of America N.A.; Merrill Lynch Pierce Fenner & Smith, Inc.; and Merrill Lynch International as the relevant subsidiaries.

What voting and dispositive powers are reported for the NVAX shares?

Shared voting power is 6,653,929 shares and shared dispositive power is 6,655,398 shares. The filing shows no sole voting or sole dispositive power for the reporting person.

What date and share total were used to compute the 4.1% ownership figure?

The calculation relies on 162,935,945 shares outstanding as disclosed in the issuer's Form 10-K. That Form 10-K reported share totals as of February 16, 2026 and is cited in the amendment.

Does this Schedule 13G/A indicate an active takeover or change in control?

No—this filing is a passive ownership disclosure, not an acquisition announcement. It classifies the position as beneficial ownership held with shared powers; it does not state any intent to change control or a purchase program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 01:02 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

NOVAVAX INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

670002401

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 670002401

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,653,929.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,655,398.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,655,398.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.1 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 162,935,945 outstanding shares disclosed in the Form 10-K by the issuer on February 26, 2026, which reports share totals as of February 16, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: NOVAVAX INC
(b)	Address of issuer's principal executive offices: 21 FIRSTFIELD RD, 21 FIRSTFIELD RD, GAITHERSBURG, MARYLAND, 20878.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 670002401
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6,655,398.00
(b)	Percent of class: 4.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 6,653,929.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 6,655,398.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch Pierce Fenner & Smith, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); and Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Monica Yako
Name/Title:	Authorized Signatory
Date:	04/27/2026